Dr Reddy’s injectable lenacapavir for HIV prevention gets tentative nod from USFDA
The first supplies are expected to reach people by the end of 2026, with broader rollout across eligible countries expected in 2027
The first supplies are expected to reach people by the end of 2026, with broader rollout across eligible countries expected in 2027
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
